# Approaches to Identify Early Biomarkers and Pathogenesis of Anthracycline Cardiotoxicity

> **NCT04036045** · — · WITHDRAWN · sponsor: **Connecticut Children's Medical Center**

## Conditions studied

- Childhood Cancer

## Interventions

- **OTHER:** Cardiac MRI
- **OTHER:** Echocardiogram
- **OTHER:** Blood Draw

## Key facts

- **NCT ID:** NCT04036045
- **Lead sponsor:** Connecticut Children's Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2018-11-12
- **Primary completion:** 2024-12
- **Final completion:** 2025-03-31
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No funding, no participation
- **Last updated:** 2025-10-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04036045

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04036045, "Approaches to Identify Early Biomarkers and Pathogenesis of Anthracycline Cardiotoxicity". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04036045. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*